Literature DB >> 7446557

Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy.

D J Cutler, J M Isner, A W Bracey, C A Hufnagel, P W Conrad, W C Roberts, D M Kerwin, A M Weintraub.   

Abstract

Cardiac involvement in hemochromatosis typically results in congestive cardiomyopathy; a restrictive cardiomyopathy due to hemochromatosis is distinctly rare. A restrictive cardiomyopathy, which developed in the patient described in this report, was due to hemochromatosis which mimicked constrictive pericarditis clinically, echocardiographically and hemodynamically, and resulted in a thoracotomy for attempted surgical therapy. The fact that hemochromatosis represents the only cause of a restrictive cardiomyopathy that is potentially reversible by medical therapy makes early recognition of hemochromatosis heart disease important.

Entities:  

Mesh:

Year:  1980        PMID: 7446557     DOI: 10.1016/s0002-9343(80)80020-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

Review 2.  The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

Authors:  David S Goldberg; Michael B Fallon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-28       Impact factor: 11.382

3.  Neoplasms involving the heart, their simulators, and adverse consequences of their therapy.

Authors:  W C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-10

4.  Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy.

Authors:  A P Fitzpatrick; L M Shapiro; A F Rickards; P A Poole-Wilson
Journal:  Br Heart J       Date:  1990-02

5.  Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1.

Authors:  M M Santos; M de Sousa; L H Rademakers; H Clevers; J J Marx; M W Schilham
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 6.  Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies.

Authors:  Babken Asatryan; Argelia Medeiros-Domingo
Journal:  J Mol Med (Berl)       Date:  2018-08-20       Impact factor: 4.599

Review 7.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

Review 8.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

9.  Clinical, hemodynamic and endomyocardial biopsy findings in idiopathic restrictive cardiomyopathy.

Authors:  J D Hosenpud; N R Niles
Journal:  West J Med       Date:  1986-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.